Clinical Significance of 64-slice Multidetector Coronary CT Angiography to Evaluate the Prevalence and Severity of Coronary Artery Disease in Renal Transplant Recipients
1 other identifier
interventional
93
1 country
1
Brief Summary
The aim of this study is to evaluate the clinical usefulness of 64-slice multidetector coronary CT angiography (MDCTA) in renal transplant recipients who had no previous coronary artery disease (CAD). Primary endpoint is to assess the prevalence and severity of coronary artery disease in patients post-transplant 6 to 12 months. CAD can be diagnosed noninvasively with similar accuracy of coronary angiography using MDCTA. Early detection and intervention of CAD may provide survival benefit in renal transplant recipients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2012
CompletedFirst Posted
Study publicly available on registry
December 20, 2012
CompletedStudy Start
First participant enrolled
February 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 28, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 28, 2014
CompletedNovember 28, 2017
November 1, 2017
1.5 years
December 17, 2012
November 26, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
prevalence of coronary artery disease
at post-transplant 6 to 12 months.
Secondary Outcomes (1)
severity of coronary artery disease
at post-transplant 6 to 12 months
Study Arms (1)
MDCTA
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- age ≥ 40 yrs
- renal transplant recipient at post-transplant 6 to 12 months
- stable graft renal function: CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation ≥45 mL/min/1.75m2
- patients who had no previous CAD
You may not qualify if:
- unstable graft renal function
- History of acute kidney injury within 3 months
- Allergic history to contrast agent
- Irregular heart beat
- Multiorgan transplant recipients
- Pregnancy
- Patients who do not consent to this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Severance hospital
Seoul, 120-752, South Korea
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2012
First Posted
December 20, 2012
Study Start
February 1, 2013
Primary Completion
July 28, 2014
Study Completion
July 28, 2014
Last Updated
November 28, 2017
Record last verified: 2017-11